Protein Kinase A Regulatory Subunits in Human Adipose Tissue

Abstract

OBJECTIVE-In human adipocytes, the cAMP-dependent pathway mediates signals originating from ␤-adrenergic activation, thus playing a key role in the regulation of important metabolic processes, i.e., lipolysis and thermogenesis. Cyclic AMP effects are mainly mediated by protein kinase A (PKA), whose R2B regulatory isoform is the most expressed in mouse adipose tissue, where it protects against diet-induced obesity and fatty liver development. The aim of the study was to investigate possible differences in R2B expression, PKA activity, and lipolysis in adipose tissues from obese and nonobese subjects. RESEARCH DESIGN AND METHODS-The expression of the different PKA regulatory subunits was evaluated by immunohistochemistry, Western blot, and real-time PCR in subcutaneous and visceral adipose tissue samples from 20 nonobese and 67 obese patients. PKA activity and glycerol release were evaluated in total protein extract and adipocytes isolated from fresh tissue samples, respectively. RESULTS-Expression techniques showed that R2B was the most abundant regulatory protein, both at mRNA and protein level. Interestingly, R2B mRNA levels were significantly lower in both subcutaneous and visceral adipose tissues from obese than nonobese patients and negatively correlated with BMI, waist circumference, insulin levels, and homeostasis model assessment of insulin resistance. Moreover, both basal and stimulated PKA activity and glycerol release were significantly lower in visceral adipose tissue from obese patients then nonobese subjects.CONCLUSIONS-Our results first indicate that, in human adipose tissue, there are important BMI-related differences in R2B expression and PKA activation, which might be included among the multiple determinants involved in the different lipolytic response to ␤-adrenergic activation in obesity. Diabetes 58: 620-626, 2009 C yclic AMP is implicated in the regulation of a variety of cell functions that are, at least in part, related to protein phosphorylation through the activation of protein kinase A (PKA). In addition to the control of differentiated functions, such as motility, secretion, metabolism, differentiation, synaptic transmission, and ion channel activities, cAMP inhibits or stimulates cell proliferation depending on the cell type. In human adipocytes, the cAMP-dependent pathway mediates signals originating from the activation of ␤-adrenergic receptors, thus playing a key role in the regulation of important metabolic processes, such as lipolysis and thermogenesis. Cyclic AMP effects are mainly mediated by PKA, a tetrameric enzyme composed of two catalytic subunits associated with two regulatory subunits. There are four different regulatory subunit genes and proteins (R1A, R1B, R2A, and R2B) expressed with a tissue-specific pattern and exerting distinct roles in cell differentiation and growth control (1). Dramatic changes in the proportion of the two PKA regulatory subunits, R1 and R2, occur during ontogenic development, differentiation processes, and neoplastic transformation, indicating d...

Mitochondria: a possible nexus for the regulation of energy homeostasis by the endocannabinoid system?

“…Together, these observations suggest that the ECS, acting through CB1R and/or CB2R, may transduce the cAMP-PKA signaling axis to regulate important mitochondrial processes such as cellular respiration, fatty acid oxidation, and ATP production. Moreover, PKA activity has been reported to be reduced in visceral adipose tissue from obese individuals (84). However, whether such obesity-induced alterations in PKA are driven by ECS hyperactivation remains to be determined.…”

Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy

“…Thus, metformin exerts its antidiabetic effects by inhibiting R101 Review h yang and l yang cAMP/PKA signaling and diabetes cAMP/PKA signaling in both adipose tissue and liver to suppress excessive lipolysis and glucose production, respectively. RIIβ is the major PKA subtype in adipose tissues in mouse (Cummings et al 1996) and human (Mantovani et al 2009, Peverelli et al 2013. In mice, RIIβ deficiency is associated with compensatory increase in RIα PKA and increased basal PKA activity in WAT and BAT.…”

“…In BAT, RIIβ deficiency leads to increases in mitochondrial content and thermogenesis (Nolan et al 2004, Newhall et al 2005. However in human, obesity is associated with reduced RIIβ expression and PKA activity in WAT (Mantovani et al 2009). βAR-stimulated lipolysis and mitochondrial respiration are also decreased in WAT of obese patients (Yehuda-Shnaidman et al 2010).…”

PKA regulatory subunit R2B is required for murine and human adipocyte differentiation

“…There are four regulatory subunits (R1A, R1B, R2A, and R2B) differently expressed in mammalian tissues, affecting cAMP-dependent functions (10). In adipose tissue, the major holoenzyme assembled under normal conditions contains the R2B regulatory subunit, even though both PRKAR2B and PRKAR1A are expressed in fat cells (11,12). Targeted disruption of the Prkar2b gene in mice leads to stable alterations in energy storage and utilization, resulting in a lean phenotype (13).…”